Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 AUG 31 ... at any time. Biovail will be consulting with its partner, Pricara (a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.) to determine next steps. The decision as to ... Treatment, U.S. Food and Drug Administration. This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business ... clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that ... steps. The decision as to whether or not to appeal the decision lies with Purdue Pharma LP, the patent holder. Biovail recorded Ultram® ER revenues of $81.9 ...
2009 AUG 31 ... extended-release tablets). The patents-in-suit are owned by Purdue and are licensed to Ortho-McNeil, Inc., the marketer of Ultram® ER. In his decision, Circuit Judge Kent ... Treatment, Ultram, Labopharm Inc. This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business ... commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram® ER (tramadol ... Actions, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Purdue Pharma LP, Therapy, Tramadol, Tramadol Hydrochloride, Treatment, Ultram, Labopharm Inc. ...
